Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 2013

View Archived Issues

XL-protein presents novel PASylated biopharmaceuticals

A potential new protein biomarker of erectile dysfunction

Promising in vitro results for a novel gene therapy for mitochondrial diseases

Novel models developed for skin diseases and SLE

Novel TRVP1 ligands disclosed by Grunenthal

Intervet International prepares new DGAT1 inhibitors

French group divulges new cystathione beta-synthase inhibitors

MedImmune presents novel antibodies targeting P. aeruginosa

Alios BioPharma begins phase I trial of first-in-class nucleoside analogue targeting RSV

Achillion Pharmaceuticals chooses novel HCV drug candidate for clinical development

Inostics receives CLIA certification for blood-based mutation testing

VBL Therapeutics presents phase I/II results for VB-111

IND-enabling study of stem cell candidate for Parkinson's disease commences

GC-1008 is well tolerated but shows no clinical benefit in patients with glioma

Grant supports Epitarget's work to develop nanoparticulate immune stimulator

Vanda Pharmaceuticals submits NDA for tasimelteon

Omeros' OMS-824 shows binding to PDE10 in PET scans

Cancer Research UK launches phase I trial of AZD-3965

E Keppra approved in Japan for pediatric epilepsy

Filgrastim biosimilars launched in Japan

European CHMP recommends approval of pomalidomide for rrMM

Novo Nordisk seeks E.U. approval of IDegLira for type 2 diabetes

Depomed to cease investment in Sefelsa following receipt of complete response letter from FDA

Otsuka files application in Japan for tolvaptan in autosomal dominant polycystic kidney disease

European CHMP recommends approval of Lojuxta

CMDh endorses EMA committee's recommendation on benefit/risk profile of Diane-35

CHMP recommends European approval of once-weekly somatropin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...